Skip to main content

DRUG · Bright Minds Biosciences Inc. · Debt

Track DRUG — free
$52.69 +2.25 (+4.46%) At close · Oct 22
Market Cap
$519.74M
Shares
9.86M
Volume · Oct 22 221.3K Avg daily vol (3M) 144.42K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2025-09-30 CAD 125,777 40-F filed 2025-12-23
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
CAD 84,528
Noncurrent lease liabilities
CAD 41,249
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1827401 CUSIP 10919W405 13F (30d) 9 filings 9 filers Visit website Investor relations